HNF1A and diabetes mellitus: The lack of optimal glycaemic control in our study may have resulted from clinical inertia or limited experience among local clinicians in managing HNF1A/HNF4A-MODY and previous advice advocating a trial of sulfonylureas even in those with longstanding diabetes [11].